Stock listing
Arcturus Therapeutics Holdings Inc.
Selected listing: ARCT · NASDAQ · USD · US
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), Health Technology. Latest release Sep 23, 2026: Arcturus Therapeutics Announces Interim OTC Deficiency…

- Ticker
- NASDAQ:ARCT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. is a public company traded on the American market under the ticker ARCT. Arcturus focuses on developing innovative RNA medicines for various diseases.
Latest news from Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform
September 23, 2026
Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
September 18, 2026
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
August 31, 2026
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
August 6, 2026
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
July 27, 2026
Events
Replays
Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
WatchArcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
WatchArcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call
Tue, Mar 03, 2026 · 04:30 PM ET
Watch
Research Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. company profile
View the public company page for Arcturus Therapeutics Holdings Inc. on 6ix.
Arcturus Therapeutics Holdings Inc. news
Read company news and market updates connected to Arcturus Therapeutics Holdings Inc..
Arcturus Therapeutics Holdings Inc. investor events
Find investor webinars, events, and replay context for Arcturus Therapeutics Holdings Inc..